Your session is about to expire
What is Simbrinza
Approved as Treatment by the FDA
Brinzolamide, also known as Azopt, is approved by the FDA for 7 uses which include Increased Intra Ocular Pressure (IOP) and Ocular Hypertension .Effectiveness
When to interrupt dosage
The quantity of Simbrinza is contingent upon the diagnosed state, such as Open Angle Glaucoma, facial erythema and Ocular Hypertension. The dosage also relies on the mode of delivery indicated in the table below.Warnings
There are 18 known major drug interactions with Simbrinza.Simbrinza Novel Uses: Which Conditions Have a Clinical Trial Featuring Simbrinza?
114 active studies are in progress to ascertain the efficacy of Simbrinza in managing Open Angle Glaucoma, inadequately controlled intraocular pressure and Open Angle Glaucoma.Simbrinza Reviews: What are patients saying about Simbrinza?
Patient Q&A Section about simbrinza
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Why was SIMBRINZA discontinued?
"11% of people taking SIMBRINZA had to stop taking it because of bad reactions. Other reactions that have been reported during clinical trials for the individual components are listed below."
What is SIMBRINZA eye drops used for?
"This product contains two medications that are used to lower the pressure in the eye for people who have glaucoma or ocular hypertension. By lowering the pressure in the eye, it reduces the risk of vision loss, nerve damage, or blindness."
Is SIMBRINZA safe to use?
"Simbrinza can make you drowsy. Be careful when driving, operating machinery, or doing other activities that could be dangerous. If you have any of the following symptoms, stop taking Simbrinza and call your doctor immediately: blurred or tunnel vision, eye pain, seeing halos around lights, eye redness, or severe discomfort."